Adaptimmune LLC

Form 483 issued April 5, 2024 · Philadelphia, Pennsylvania

Inspection
Apr 1 – Apr 5, 2024
Observations
5
Pages
4
FEI number
3013525969

In short: On April 5, 2024, FDA issued a Form 483 with 5 observations to Adaptimmune LLC in Philadelphia, Pennsylvania (FEI 3013525969) after an inspection that ran Apr 1 – Apr 5, 2024. The investigators were Anna Kwilas, Elvira Argus and Viviana Ramirez. Most observations concern quality system and materials; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and materials account for 3 of 5 observations.

Quality system2
Materials1
Production1
Laboratory controls1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There are multiple instances in which the root causes identified from deviation investigations are not adequately…

  2. 02

    There are deficiencies in the incoming testing of critical…

  3. 03

    Deviations and/or observations that occur during manufacturing are not always documented appropriately…

  4. 04

    Defined procedures for retesting for Out of Specification results…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Adaptimmune LLC?

FDA listed 5 observations on this Form 483, mostly about quality system, materials and production. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Adaptimmune LLC?

Anna Kwilas, Elvira Argus and Viviana Ramirez are named on this Form 483, for the inspection of Apr 1 – Apr 5, 2024. Each investigator has a profile showing what they cite most.

When was Adaptimmune LLC inspected by FDA?

The inspection ran Apr 1 – Apr 5, 2024, and the Form 483 is dated April 5, 2024.

How do I get the full Form 483 for Adaptimmune LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free